Ability of the VITEK 2 advanced expert system to identify β-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa

Journal of Clinical Microbiology

Volumn 38, Issue 2, 2000, Pages 570-574

  Sanders, Christine C ^a   Peyret, Michel ^b   Moland, Ellen Smith ^a   Shubert, Carole ^b   Thomson, Kenneth S ^a   Boeufgras, Jean Marc ^b   Sanders Jr , W Eugene ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIMENTIN;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; ENTEROBACTERIACEAE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0033973437     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.2.570-574.2000     Document Type: Article

References (18)

1. Bauernfeind, A., H. Grimm, and S. Schweighart. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298.
2. Bradford, P. A., and C. C. Sanders. 1995. Development of test panel of β-lactamases expressed in a common Escherichia coli host background for evaluation of new β-lactam antibiotics. Antimicrob. Agents Chemother. 39:308-313.
3. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
4. Courvalin, P. 1992. Interpretive reading of antimicrobial susceptibility tests. ASM News 58:368-375.
5. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
6. Matthew, M. A., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
7. Medeiros, A. A. 1997. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin. Infect. Dis. 24(Suppl. 1): S19-S45.
8. Moland, E. S., C. C. Sanders, and K. S. Thomson. 1998. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of β-lactamase production among Escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam? J. Clin. Microbiol. 36:2575-2579.
9. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. O'Callaghan, C. H., P. W. Muggleton, and G. W. Ross. 1969. Effects of β-lactamase from gram-negative organisms on cephalosporin and penicillins, p. 57-63. Antimicrob. Agents Chemother. 1968.
11. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
12. Sanders, C. C. 1992. β-Lactamases of gram-negative bacteria: new challenges for new drugs. Clin. Infect. Dis. 14:1089-1099.
13. Sanders, C. C., A. L. Barry, J. A. Washington, C. Shubert, E. S. Moland, M. M. Traczewski, C. Knapp, and R. Mulder. 1996. Detection of extended-spectrum-β-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test. J. Clin. Microbiol. 34:2997-3001.
14. Sanders, C. C., M. L. Gates, and W. E. Sanders, Jr. 1988. Heterogeneity of class I β-lactamase expression in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 32:1893-1895.
15. Sanders, C. C., and W. E. Sanders, Jr. 1992. β-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 15:824-839.
16. Sanders, C. C., W. E. Sanders, Jr., and E. S. Moland. 1986. Characterization of β-lactamases in situ on polyacrylamide gels. Antimicrob. Agents Chemother. 30:951-952.
17. Thomson, K. S., C. C. Sanders, and E. S. Moland. 1999. Use of microdilution panels with and without β-lactamase inhibitors as a phenotypic test for β-lactamase production among E. coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens. Antimicrob. Agents Chemother. 43:1393-1400.
18. Vercauteren, E., P. Descheemaeker, M. Ieven, C. C. Sanders, and H. Goossens. 1997. Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J. Clin. Microbiol. 35:2191-2197.